Maternal HIV-1 RNA serum levels at delivery and vertical transmission in Uganda

Pediatric AIDS and HIV Infection

Volumn 7, Issue 1, 1996, Pages 37-42

  Brooks Jackson, J ^a   Horn, David ^a   Piwowar, Estelle ^a   Ndugwa, Christopher ^a   Kataaha, Peter ^a   Marum, Lawrence ^a   Quay, Laura ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; UGANDA; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS TITRATION; VIRUS TRANSMISSION;

CASE-CONTROL STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RNA, VIRAL; STATISTICS, NONPARAMETRIC; UGANDA;

EID: 0029897805     PISSN: 10455418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hutto C, Parks WP, Lai S, et al., A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1. JPediatr 1991;! 18:347-53.
2. European Collaborative Study, Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-12.
3. Ryder RW, Nsa W, Hassig SE, et al., Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989:320:1637-42.
4. Blanche S, Rouzioux C, Moscato MLG, et al., A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989;320:1643-8.
5. Halsey NA, Boulos R, Hold E, et al., Transmission of HIV-1 infections from mothers to infants in Haiti. JAMA 1990;264: 2088-92.
6. Italian Multicentre Study. Epidemiology, clinical features and prognostic factors of paediatric HIV infection. Lancet 1988;ii: 1043-6.
7. Boue F, Pons JC, Keros L, et al., Risk for HIV-1 perinatal transmission vary with the mother's stage of HIV infection. VI International Conference on AIDS, San Francisco, CA. June 1990, Abstract Th.C.44.
8. St. Louis ME, Kabagabo U, Brown C, et al., Maternal factors associated with perinatal HIV transmission. Vllth International Conference on AIDS. Florence, Italy. June 17/18, 1991. Abstract M.C. 3027.9.
9. Rossi P, Moschese V, Broliden PA, et al., Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein correlates with the uninfected status of children born to seropositive mothers. Proc Natl Acad Sei 1989;86:8055-8.
10. Devash Y, Calvelli TA, Wood DG, et al, Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp!20 principal neutralizing domain. Proc Natl Acad Sei USA 1990:87: 3445-9.
11. D'Arminio MA, Ravizza M, Muggiasca ML, et al., HIV-infected women: possible predictors of vertical transmission. VII International Conference on AIDS, Florence, Italy, June 1991, Abstract W.C. 49.
12. Kreiss J, Datta P, Willerford, et al.. Vertical transmission of HIV in Nairobi: correlation with maternal viral burden. VII International Conference on AIDS, Florence, Italy, June 1991, Abstract M.C. 3062.
13. Jackson JB, Kataaha P, Horn DL, et al., B2-microglobulin, HIV1 p24 antibody, and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women. AIDS 1993;7:1475-9.
14. Pachl C, Todd JA, Kern DG, et al.. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immun Defic Syndr 1995:8:446-54.
15. Mulder J, McKinney N. Christopherson C, et al.. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
16. Van Gemen B, Kievits T, Nara P, et al., Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification. AIDS 1993;7:S 107-10.
17. Mellors JW, Kingsley LA, Rinaldo CR, et al., Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Int Med 1995:122:573-9.
18. Hooper C, Welles S, D'Aquila R, et al., HIV-1 RNA level in plasma and association with disease progression, zidovudine sensitivity phenotype and genotype, syncytium-inducing phenotype, CD4+ cell count and clinical diagnosis of AIDS, [abstract 67] HIV Drug Resistance Third International Workshop. Kauai, Hawaii. August 2-5, 1994.
19. Welles SL, Jackson JB, Yen-Lieberman B, et al., Prognostic capacity of plasma HIV-1 RNA copy number in ACTG 116A. [abstract 230]. In: Program and Abstracts of the Second National Conference on Human Retroviruses and Related Infections. Washington, DC. January 29, 1995.
20. O'Brien WA, Hartigan P, McCreedy B, Hamilton JD, Predictive value of plasma HIV-1 RNA and 82 microglobulin in determining clinical outcome, [abstract 1208] In: Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, FL. October 4-7, 1994.
21. Fang G, Burger H, Tropper P, et al., QC-PCR quantitation of HIV plasma RNA level during pregnancy: relationship to mother-to-child transmission and antiviral therapy, [abstract 441]. In: Program and Abstracts of the 2nd National Conference on Human Retroviruses and Related Infections. Washington, DC. February 1, 1995.
22. Dickover R. Herman S, Garraty E, et al., Maternal HIV RNA levels are directly related to perinatal transmission risk and significantly reduced by ZDV treatment. J Cell Biochem 1995;supp] 21b:233.
23. Marum L, Guay L, Mmiro F, et al., Mother to child transmission in Uganda, [abstract 219C]. In: Abstracts of the Tenth International Conference on AIDS. Yokahama, Japan, August 1994.
24. Dabis F, Msellati P, Dünn D, et al., Estimating the rate of motherto-child transmission of HIV. Report of a workshop on methodological issues Ghent (Belgium), 17-20 February 1992. AIDS 1993:7:1139-48.
25. World Health Organization: Provisional WHO clinical case definition for AIDS, Wkly Epidemiol Rec 1986; 10:69-70.
26. Lin HJ, Myers LE, Yen-Lieberman B, et al., Multicenter evaluation of methods for the quantitation of plasma HIV-1 RNA. J Infec Dis 1994; 170:553-62.
27. Ascher DP, Roberts C, Fowler A. Acidification modified p24 antigen capture assay in HIV seropositives. J Acquir Immunodefic Syndr 1992;5:1080-3.
28. Brown BW, Hollander M, Statistics: A biomédical introduction. New York: Wiley & Sons, 1977.
29. Norusis MJ, SPSS for Windows Release 6.0. Chicago, IL: SPSS Inc. 1993.
30. Holodniy M, Mole L, Yen-Lieberman B, et al., Comparative stability of quantitative HIV plasma RNA from samples collected in VACUTAINER CPT, VACUTAINER PPT and standard VACUTAINER tubes. J Clin Microbiol 1995;33: 1562-6.
31. WHO network for HIV isolation and characterization, HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: Genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res Hum Retroviruses 1994;10:13273.